Quarterly Activities Report & Appendix 4C - 31 December 2017
Filed with ASX · · 13 pages · English
• Completed a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month • Ohio State University: patient recruitment for the collaborative clinical research study commenced 1 November • Progressed with the comprehensive initiative to explore a wide range of strategic opportunities • Regained compliance with Nasdaq Marketplace Listing Rule, without the need
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Response to ASX Price Query
- Update on Strategic Review Initiative
- Quarterly Activities Report - 30 September 2017
- Transition to Online Commercial Platform for BREVAGenplus
- Appendix 4E and Financial Report 2017
Later from Genetic Technologies
- Results from 31 January 2018 General Meeting
- Voluntary Suspension from Official Quotation
- Change of Chief Executive Officer
- Strategic Alliance and Capital Raising
- Appendix 4D & Half Year Financial Report - 31 December 2017
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies